首页|Data from Cedars Sinai Medical Center Provide New Insights into Experimental Lung Transplants (Robotic-assisted Lung Transplantation: First In Man)
Data from Cedars Sinai Medical Center Provide New Insights into Experimental Lung Transplants (Robotic-assisted Lung Transplantation: First In Man)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
Elsevier
Research findings on Transplant Medicine - Experimental Lung Transplants are dis-cussed in a new report. According to news reporting originating from Los Angeles, California, by NewsRx correspondents, research stated, “Lung transplantation remains the best option for patients with end-stage lung disease.” Our news editors obtained a quote from the research from Cedars Sinai Medical Center, “However, this operation has historically carried significant potential morbidity. To improve near-term patient outcomes, attempts have been made to decrease invasiveness, but this is limited by the complex nature of the operation and the anatomy of the chest.” According to the news editors, the research concluded: “To facilitate further reduction in incision size and augment our existing minimally invasive approach, we developed a novel technique utilizing the Da Vinci robotic system to implant a right lung in a 69-year-old recipient.(.” This research has been peer-reviewed.
Los AngelesCaliforniaUnited StatesNorth and Central AmericaBiomedicineEmerging TechnologiesExperimental Lung TransplantsHealth and MedicineMachine LearningRoboticsRobotsSurgeryTransplant MedicineCedars Sinai Medical Center
NETL
NSTL
Elsevier
